Boston An independent LDT provider


Our in-house production is fully compliant with general regulatory requirements for EN ISO 13485.

Click on image below for larger size.

Antibody Production and Purification Process

Recombinant scFv antibodies are produced and purified in-house. Our vast library of recombinant scFv antibodies, has been specifically designed at the molecular level, to give a reliable source of renewable high-quality recombinant scFv antibodies to ensure optimal on-chip functionality.

Microarray Production

Antibody microarrays for multiplexed protein detection in blood samples are produced by a high-throughput, a non-contact robotic printing system which prints ultra-low volumes (picoliters) of antibodies onto a solid support. IMMray™ biomarker signature microarrays provide simultaneous measurement of the selected biomarkers in 6 patient samples, run in duplicate.


  1. Ingvarsson J et al.Proteomics 2008 8(11):2211-9.
  2. Wingren et al. Cancer Res. 2012 15;72(10):2481-90.
  3. Gerdtsson et al. Int Journal of Proteomics 2015;2015:587250.
  4. Gerdtsson et al. J Mol Oncol, 2016. 10, 1305-1316.
  5. Mellby et al. Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer. Journal of Clinical Oncology. 2018 Aug;36(28):2887-2894.